Science Explorer Back to mapMap
Discussion
Researcher · Kenyon College · United States

Matthew Turek

Matthew Turek publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Molecular Biology, on topics such as Prostate Cancer Treatment and Research, Peptidase Inhibition and Analysis and Protein Tyrosine Phosphatases.

OpenAlex
World rank
#7,710,332
of 7,710,434 ranked researchers
Rank in United States
#1,627,041
of 1,627,098
Works
879
Citations
0
h-index
0
i10-index 0Top 100% in Oncology
Matthew Turek

What does Matthew Turek research?

Matthew Turek's work is mostly in Medicine (78%), Biochemistry, Genetics and Molecular Biology (14%), Pharmacology, Toxicology and Pharmaceutics (6%).

Health Sciences: 689 works · 78.4% of their workMedicine: 689 works · 78.4% of their workOncology: 323 works · 36.8% of their workPulmonary and Respiratory Medicine: 272 works · 31.0% of their workSurgery: 82 works · 9.3% of their workHematology: 11 works · 1.3% of their workLife Sciences: 172 works · 19.6% of their workBiochemistry, Genetics and Molecular Biology: 120 works · 13.7% of their workMolecular Biology: 120 works · 13.7% of their workPharmacology, Toxicology and Pharmaceutics: 52 works · 5.9% of their workPharmaceutical Science: 52 works · 5.9% of their workEverything else: 18 works · 2.0% of their workTHEIR WORKMatthew Turek879works
Life Sciences20%Health Sciences78%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine68978.4%
    1. Biochemistry, Genetics and Molecular Biology12013.7%
    2. Pharmacology, Toxicology and Pharmaceutics525.9%
  3. Everything else182.0%
  1. 1Oncology37% of their works
  2. 2Pulmonary and Respiratory Medicine31% of their works
  3. 3Molecular Biology14% of their works
  4. 4Surgery9% of their works
  5. 5Pharmaceutical Science6% of their works
  6. 6Hematology1% of their works

Research topics

Which keywords describe Matthew Turek's research?

The keywords of their largest research topics: Cancer Therapy, Androgen Receptor, Prostate Cancer, Fibroblast Activation Protein, Tumor Microenvironment, Protein Tyrosine Phosphatases, PTPN11 and Heparin-Induced Thrombocytopenia.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 17 words, with their numbers
  1. Cancer Therapy9512 topics
  2. Androgen Receptor8171 topic
  3. Prostate Cancer8171 topic
  4. Fibroblast Activation Protein7591 topic
  5. Tumor Microenvironment7591 topic
  6. PTPN112571 topic
  7. Protein Tyrosine Phosphatases2571 topic
  8. Heparin-Induced Thrombocytopenia2451 topic
  9. Thrombosis2451 topic
  10. BRCA Mutation1921 topic
  11. PARP Inhibitors1921 topic
  12. Deuterium1551 topic
  13. Drug Discovery1551 topic
  14. DNA881 topic
  15. Topoisomerases881 topic
  16. Diagnosis Criteria241 topic
  17. International Myeloma Working Group241 topic

Where does Matthew Turek work?

Matthew Turek's main affiliation in the publication record is Kenyon College, United States.

How many publications and citations does Matthew Turek have?

OpenAlex counts 879 works and 0 citations for Matthew Turek, an h-index of 0, ranking #7,710,332 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Matthew Turek

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Matthew Turek. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.